BDBM752327 (1R,3S,5R)-2-(2-(3-acetyl- 6-fluoro-7-methyl-5-(2- methyl-[1,2,4]triazolo[1,5- a]pyridin-6-yl)-1H-indol- 1-yl)acetyl)-N-(3-(meth- oxymethyl)-6-(trifluoro- methyl)pyridin-2-yl)-5- methyl-2-azabicyclo[3.1.0] hexane-3-carboxamide::US20250197403, Compound 5

SMILES COCc1ccc(C(F)(F)F)nc1NC(=O)[C@@H]1C[C@@]2(C)C[C@H]2N1C(=O)Cn1cc(C(C)=O)c2cc(-c3ccc4nc(C)nn4c3)c(F)c(C)c21

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752327   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752327((1R,3S,5R)-2-(2-(3-acetyl- 6-fluoro-7-methyl-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent